Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(10):715-723; doi:10.1093/jnci/dji128
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Freedman, A. N.
Right arrow Articles by Pfeiffer, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freedman, A. N.
Right arrow Articles by Pfeiffer, R. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

COMMENTARY

Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application

Andrew N. Freedman, Daniela Seminara, Mitchell H. Gail, Patricia Hartge, Graham A. Colditz, Rachel Ballard-Barbash, Ruth M. Pfeiffer

Affiliations of authors: Division of Cancer Control and Population Sciences (ANF, DS, RB-B) and Division of Cancer Epidemiology and Genetics (MHG, PH, RMP), National Cancer Institute, Bethesda, MD; Department of Epidemiology, Harvard School of Public Health, Boston, MA (GAC)

Correspondence to: Andrew N. Freedman, PhD, National Cancer Institute, National Institutes of Health, EPN 4005 MSC 7344, 6130 Executive Blvd., Bethesda, MD 20892–7344 (e-mail: Andrew_Freedman{at}nih.gov).

Cancer researchers, clinicians, and the public are increasingly interested in statistical models designed to predict the occurrence of cancer. As the number and sophistication of cancer risk prediction models have grown, so too has interest in ensuring that they are appropriately applied, correctly developed, and rigorously evaluated. On May 20–21, 2004, the National Cancer Institute sponsored a workshop in which experts identified strengths and limitations of cancer and genetic susceptibility prediction models that were currently in use and under development and explored methodologic issues related to their development, evaluation, and validation. Participants also identified research priorities and resources in the areas of 1) revising existing breast cancer risk assessment models and developing new models, 2) encouraging the development of new risk models, 3) obtaining data to develop more accurate risk models, 4) supporting validation mechanisms and resources, 5) strengthening model development efforts and encouraging coordination, and 6) promoting effective cancer risk communication and decision-making.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
P. K. J. Han, W. M. P. Klein, T. C. Lehman, H. Massett, S. C. Lee, and A. N. Freedman
Laypersons' Responses to the Communication of Uncertainty Regarding Cancer Risk Estimates
Med Decis Making, May 1, 2009; 29(3): 391 - 403.
[Abstract] [PDF]


Home page
Am. J. Roentgenol.Home page
J. Chhatwal, O. Alagoz, M. J. Lindstrom, C. E. Kahn Jr., K. A. Shaffer, and E. S. Burnside
A Logistic Regression Model Based on the National Mammography Database Format to Aid Breast Cancer Diagnosis
Am. J. Roentgenol., April 1, 2009; 192(4): 1117 - 1127.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. N. Freedman, M. L. Slattery, R. Ballard-Barbash, G. Willis, B. J. Cann, D. Pee, M. H. Gail, and R. M. Pfeiffer
Colorectal Cancer Risk Prediction Tool for White Men and Women Without Known Susceptibility
J. Clin. Oncol., February 10, 2009; 27(5): 686 - 693.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
V. S. Pankratz, L. C. Hartmann, A. C. Degnim, R. A. Vierkant, K. Ghosh, C. M. Vachon, M. H. Frost, S. D. Maloney, C. Reynolds, and J. C. Boughey
Assessment of the Accuracy of the Gail Model in Women With Atypical Hyperplasia
J. Clin. Oncol., November 20, 2008; 26(33): 5374 - 5379.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. J. Heine, M. J. Carston, C. G. Scott, K. R. Brandt, F.-F. Wu, V. S. Pankratz, T. A. Sellers, and C. M. Vachon
An Automated Approach for Estimation of Breast Density
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3090 - 3097.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
J. K. Field
Lung Cancer Risk Models Come of Age
Cancer Prevention Research, September 1, 2008; 1(4): 226 - 228.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. A. Colditz and D. M. Winn
Criteria for the Evaluation of Large Cohort Studies: An Application to the Nurses' Health Study
J Natl Cancer Inst, July 2, 2008; 100(13): 918 - 925.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. J. Wang, C. D. Fuller, J.-S. Kim, D. F. Sittig, C. R. Thomas Jr, and P. M. Ravdin
Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy for Gallbladder Cancer
J. Clin. Oncol., May 1, 2008; 26(13): 2112 - 2117.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Iasonos, D. Schrag, G. V. Raj, and K. S. Panageas
How To Build and Interpret a Nomogram for Cancer Prognosis
J. Clin. Oncol., March 10, 2008; 26(8): 1364 - 1370.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. A. Tice, S. R. Cummings, R. Smith-Bindman, L. Ichikawa, W. E. Barlow, and K. Kerlikowske
Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model
Ann Intern Med, March 4, 2008; 148(5): 337 - 347.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. T. Chlebowski, G. L. Anderson, D. S. Lane, A. K. Aragaki, T. Rohan, S. Yasmeen, G. Sarto, C. A. Rosenberg, F. A. Hubbell, and For the Women's Health Initiative Investigators
Predicting Risk of Breast Cancer in Postmenopausal Women by Hormone Receptor Status
J Natl Cancer Inst, November 21, 2007; 99(22): 1695 - 1705.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
X. Wu, J. Lin, H. B. Grossman, M. Huang, J. Gu, C. J. Etzel, C. I. Amos, C. P. Dinney, and M. R. Spitz
Projecting Individualized Probabilities of Developing Bladder Cancer in White Individuals
J. Clin. Oncol., November 1, 2007; 25(31): 4974 - 4981.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R. J Santen, N. F Boyd, R. T Chlebowski, S. Cummings, J. Cuzick, M. Dowsett, D. Easton, J. F Forbes, T. Key, S. E Hankinson, et al.
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model
Endocr. Relat. Cancer, June 1, 2007; 14(2): 169 - 187.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. R. Spitz, W. K. Hong, C. I. Amos, X. Wu, M. B. Schabath, Q. Dong, S. Shete, and C. J. Etzel
A Risk Model for Prediction of Lung Cancer
J Natl Cancer Inst, May 2, 2007; 99(9): 715 - 726.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. Wang, S. Chen, K. A. Brune, R. H. Hruban, G. Parmigiani, and A. P. Klein
PancPRO: Risk Assessment for Individuals With a Family History of Pancreatic Cancer
J. Clin. Oncol., April 10, 2007; 25(11): 1417 - 1422.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. G. Elmore and S. W. Fletcher
The Risk of Cancer Risk Prediction: "What Is My Risk of Getting Breast Cancer?"
J Natl Cancer Inst, December 6, 2006; 98(23): 1673 - 1675.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Decarli, S. Calza, G. Masala, C. Specchia, D. Palli, and M. H. Gail
Gail Model for Prediction of Absolute Risk of Invasive Breast Cancer: Independent Evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition Cohort
J Natl Cancer Inst, December 6, 2006; 98(23): 1686 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
A. J. Vickers and E. B. Elkin
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
Med Decis Making, November 1, 2006; 26(6): 565 - 574.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
W. E. Barlow, E. White, R. Ballard-Barbash, P. M. Vacek, L. Titus-Ernstoff, P. A. Carney, J. A. Tice, D. S. M. Buist, B. M. Geller, R. Rosenberg, et al.
Prospective breast cancer risk prediction model for women undergoing screening mammography.
J Natl Cancer Inst, September 6, 2006; 98(17): 1204 - 1214.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. L. Meyskens Jr and D. F. Ransohoff
Predicting Risk for the Appearance of Melanoma
J. Clin. Oncol., August 1, 2006; 24(22): 3522 - 3523.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al.
Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward
Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.